Now What? Assessing and Pivoting in the Face of Biologic "Failure"
Get every episode summarized
Each time The Dermalorian Podcast publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
About this episode
What’s the difference between primary and secondary failure of a biologic? And why does it matter? Exploring an actual patient case, faculty from the DEF Biologic and Small Molecule NP/PA CME Bootcamp—April Armstrong, MD, MPH; David E. Cohen, MD, MPH; Kara Gooding, MMS, PA-C; and Joe Gorelick, MSN, FNP-C—address these questions and many more. Plus, Mary Beth Hagan, Founder of TITAN Aesthetic Recruiting, gives tips for PAs and NPs interested in cosmetic dermatology, and there are changes coming to iPLEDGE for isotretinoin.
Like what you're hearing? Want to learn more about the Dermatology Education Foundation? Explore assets and resources on our website.
Get every episode summarized
Each time The Dermalorian Podcast publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from The Dermalorian Podcast
Still a Big Need: The Dermatology NP/PA Market in 2026
The Dermalorian Podcast
Start from Scratch: Approaches to Itch
The Dermalorian Podcast
MOA FYI: Where Do Emerging AD and PsO Treatments Fit?
The Dermalorian Podcast
Tea Time: Can't-miss Dermatology Developments in 2025
The Dermalorian Podcast